Pré-THETA: Study of Prevalence of Eating Disorder in Liver Transplant Patients
Study Details
Study Description
Brief Summary
The main goal of this observational study is to measure the prevalence of binge eating disorder in liver transplant patients by evaluating the responses to the Bulimia Test.
Secondary objectives of the study are to:
-
Determine the prevalence of binge eating disorders in liver transplant patients following alcoholic cirrhosis, evaluated by the Bulimia Test;
-
Study the association between the presence of eating disorder behaviours and liver damage : hepatic steatosis and fibrosis determined by Fibroscan (Transient elastography and controlled attenuation parameter)
-
Study the association between presence of eating disorder behaviours and alcohol use disorder, measured by Alcohol Use Disorders Identification Test-Consumption
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Liver transplant patients This cohort will consist of all liver transplant patients followed between 01/01/2023 and 06/30/2024 |
Outcome Measures
Primary Outcome Measures
- Prevalence of binge eating disorder in liver transplant patients [1 year]
The prevalence is defined as the percentage of liver transplant patients with a score higher than 88 on the Bulimia Test-Revised. The Bulimia Test-Revised is a validated test. It is a 36 item self-report questionnaire to assess the presence of bulimic symptoms. Scores range from 29-140 with those greater than 104 being indicative of bulimia nervosa.
Secondary Outcome Measures
- Prevalence for binge eating disorder in liver transplant patients following alcoholic cirrhosis [1 year]
The prevalence was defined as the percentage of liver transplant patients following alcoholic cirrhosis with a score higher than 88 on the Bulimia Test-Revised. The Bulimia Test-Revised is a validated test. It is a 36 item self-report questionnaire to assess the presence of bulimic symptoms. Scores range from 29-140 with those greater than 104 being indicative of bulimia nervosa.
- Correlation between the BulimiaTest-Revised score and liver damage determined by the Fibroscan [1 year]
The Correlation was defined by the coefficient between the bulimia-Test score and the liver damage defined by the levels of hepatic steatosis and fibrosis witch are measured by Transient elastography and controlled attenuation parameter using Fibroscan. The Bulimia Test-Revised is a validated, it is a 36 item self-report questionnaire to assess the presence of bulimic symptoms. Scores range from 29-140 with those greater than 104 being indicative of bulimia nervosa.
- Correlation between the Bulimia-Test score and the Alcohol Use Disorders Identification Test-Consumption score [1 year]
The Correlation was defined by the coefficient between the bulimia-Test score and the Alcohol Use Disorders Identification Test-Consumption score. The Bulimia Test-Revised is a validated. It is a 36 item self-report questionnaire to assess the presence of bulimic symptoms. Scores range from 29-140 with those greater than 104 being indicative of bulimia nervosa. The Alcohol Use Disorders Identification Test-Consumption score is a validated test. It's scored on a scale of 0-12 (scores of 0 reflect no alcohol use). For men, a score of 4 or more is considered positive; for women, a score of 3 or more is considered positive. Generally, the higher the AUDIT-C score, the more likely the patient's drinking is affecting his/her health and safety.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
over 18 years old
-
had a liver transplant and followed at University Hospital of Poitiers
-
responded to the Bulimia Test-Revised and to the Alcohol Use Disorders Identification Test-Consumption
-
had a Fibroscan within the year
Exclusion Criteria:
- Patient without Fibroscan and not responded to both scale : Bulimia Test-Revised and Alcohol Use Disorders Identification Test-Consumption
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre Hospitalier Henri Laborit | Poitiers | France | ||
| 2 | University Hospital of Poitiers (CHU de Poitiers) | Poitiers | France |
Sponsors and Collaborators
- Centre Hospitalier Henri Laborit
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- F20230719110020